Application 206002
- Type
- ANDA
- Sponsor
- ALVOGEN PINE BROOK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BOSENTAN | BOSENTAN | TABLET;ORAL | 62.5MG | No | No |
| 002 | BOSENTAN | BOSENTAN | TABLET;ORAL | 125MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206002-001 | BOSENTAN | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | ||
| A206002-002 | BOSENTAN | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A206002-001 | BOSENTAN | 62.5MG | TABLET / ORAL | 2019-04-26 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A206002-002 | BOSENTAN | 125MG | TABLET / ORAL | 2019-04-26 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-09-15 20:21 UTC | 2019-09 | A206002-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A206002-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A206002-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A206002-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bosentan | BOSENTAN | Zydus Pharmaceuticals USA Inc. | 8444da17-6c31-492b-8842-93740f083d9d | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | Bosentan BOSENTAN |
| bosentan | BOSENTAN | Zydus Lifesciences Limited | b88cc559-93ae-42db-9c38-fb5e9c4802e6 | 2026-02-14 | bosentan BOSENTAN | |
| Bosentan | BOSENTAN | Sun Pharmaceutical Industries, Inc. | c006d8ef-8cb7-4fb3-88eb-b2debc302a20 | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | Bosentan BOSENTAN |
| bosentan | BOSENTAN | Actavis Pharma, Inc. | 39b2a85f-4322-42d4-b420-1b1d52569143 | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | bosentan BOSENTAN |
| Tracleer | BOSENTAN | Actelion Pharmaceuticals US, Inc. | 749e42fb-2fe0-45dd-9268-b43bb3f4081c | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | BOSENTAN |
| bosentan | BOSENTAN | Zydus Pharmaceuticals USA Inc. | c1e75179-cbea-4535-8709-f6d79c1d4004 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | bosentan BOSENTAN |
| Bosentan | BOSENTAN | Lupin Pharmaceuticals, Inc. | 540b6f6a-79f3-4681-8c2a-268cf7cecbc9 | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | Bosentan BOSENTAN |
| Bosentan | BOSENTAN | Zydus Lifesciences Limited | 02892f47-0d59-4254-9ee7-d524278fdd79 | 2024-11-25 | Bosentan BOSENTAN |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-270 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-270 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-270 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-270 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-271 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-271 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-271 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |
| 47781-271 | Bosentan | Bosentan | Alvogen Inc. | ANDA | Current |